Lainchbury; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lainchbury; Michael.The latest application filed is for "cinnoline compounds and uses thereof".

Company Profile

4.10.17

Lainchbury; Michael - Harlow GB
LAINCHBURY; Michael - Harlow Essex GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cinnoline Compounds And Uses Thereof App 20220073520 - Malhotra; Sushant ; et al.	2022-03-10
Azaindoles As Inhibitors Of Hpk1 App 20210299110 - HEFFRON; Timothy ; et al.	2021-09-30
5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof App 20210276990 - Collins; Ian ; et al.	2021-09-09
Naphthyridine Compounds And Uses Thereof App 20210277024 - Kellar; Terry ; et al.	2021-09-09
Isoquinoline Compounds And Uses Thereof App 20210253580 - Liang; Jun ; et al.	2021-08-19
Naphthyridines as inhibitors of HPK1 Grant 11,034,692 - Chan , et al. June 15, 2	2021-06-15
Isoquinolines As Inhibitors Of Hpk1 App 20210163417 - Chan; Bryan ; et al.	2021-06-03
Azaindoles as inhibitors of HPK1 Grant 10,952,995 - Heffron , et al. March 23, 2	2021-03-23
Azaindoles As Inhibitors Of Hpk1 App 20200000780 - HEFFRON; Timothy ; et al.	2020-01-02
Naphthyridines as inhibitors of HPK1 Grant 10,407,424 - Chan , et al. Sept	2019-09-10
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof Grant 10,259,806 - Collins , et al.	2019-04-16
Naphthyridines As Inhibitors Of Hpk1 App 20180282328 - Chan; Bryan ; et al.	2018-10-04
Isoquinolines As Inhibitors Of Hpk1 App 20180282282 - Chan; Bryan ; et al.	2018-10-04
Azaindazole compounds as inhibitors of T790M containing EGFR mutants Grant 9,951,064 - Bryan , et al. April 24, 2	2018-04-24
Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants Grant 9,890,152 - Bryan , et al. February 13, 2	2018-02-13
5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof App 20180022739 - Collins; Ian ; et al.	2018-01-25
5-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Grant 9,765,059 - Collins , et al. September 19, 2	2017-09-19
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]py- razine-2-carbonitrile and therapeutic uses thereof Grant 9,663,503 - Collins , et al. May 30, 2	2017-05-30
5-(Pyridin-2-yl-Amino)-Pyrazine-2-Carbonitrile Compounds and Their Therapeutic Use App 20160304493 - Collins; Ian ; et al.	2016-10-20
Azaindazole Compounds As Inhibitors Of T790m Containing Egfr Mutants App 20160257682 - Bryan; Marian C. ; et al.	2016-09-08
5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Grant 9,403,797 - Collins , et al. August 2, 2	2016-08-02
Aminopyrimidine Compounds As Inhibitors Of T790m Containing Egfr Mutants App 20160016948 - Bryan; Marian C. ; et al.	2016-01-21
5-(Pyridin-2-yl-Amino)-Pyrazine-2-Carbonitrile Compounds and Their Therapeutic Use App 20150225372 - Collins; Ian ; et al.	2015-08-13
5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Grant 9,040,540 - Collins , et al. May 26, 2	2015-05-26
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]py- Razine-2-carbonitrile And Therapeutic Uses Thereof App 20150126471 - Collins; Ian ; et al.	2015-05-07
5-(Pyridin-2-yl-Amino)-Pyrazine-2-Carbonitrile Compounds and Their Therapeutic Use App 20140315925 - Collins; Ian ; et al.	2014-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.